alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EX-10.8



 Exhibit 10.8 
  





 
 Melissa How 
 ASV LLC 

840 Lily Lane 
 Grand Rapids, MN. 

November 29, 2016 
 Dear Missi, 

Subject to your agreement to the terms in the CFO employment agreement we have discussed, dated 10/19/2016, I am pleased to make the following amendments to
your current employment letter with ASV LLC, effective as of the date of this letter or as specified. 
  

	 	1.	Salary: Effective October 1, 2016 your annual salary will be $150,000. 

  

	 	2.	In the event that the company terminates your employment for other than Cause, you shall be entitled to receive, upon satisfying the Release Condition, (i) an amount of cash equal to six months of Base Salary, to
be paid in installments in accordance with the Company’s regular payroll practices over a six month period; (ii) health plan continuation coverage in accordance with COBRA, and subject to all terms and conditions thereof.


  

	 	3.	In the event that you have remained in your position as Finance Director of ASV, and fully participated in the business and its activities including any potential transaction (sale or IPO), the following payments will
be made: Retention bonus of $20k, payable by March 31st 2017. 

  

	 	4.	In the event that a transaction (sale or IPO) is not completed by September 30, 2017, and only if a transaction has not occurred, and you have remained in your position as Finance Director of ASV, and fully
participated in the business and its activities including any potential transaction an additional retention bonus of $20k will be paid on September 30, 2017. 


 

	
	On behalf of ASV LLC.
	
	/s/ Andrew M. Rooke
	A.M. Rooke
	
	Managing Member
| EXHIBIT 99.2 |
|--------------|

| CERTIFICATION OF PERIODIC FINANACIAL REPORTS |
|----------------------------------------------|
| OF                                           |
| EXPRESSJET HOLDINGS, INC.                    |

I, Frederick S. Cromer, Vice President and Chief Financial Officer of ExpressJet Holdings, Inc., certify, pursuant to Section906 of the Sarbanes-Oxley Act of 2002 (subsections (2) and (b) of Section 1350, Chapter 63 of Title 18, United States code),that:
| (1)   | the Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2003 (the “Periodic Report”) which thisstatement accompanies fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15U.S.C. 78m or 78o (d)) and |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)   | information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results ofoperations of ExpressJet Holdings, Inc.                                                                                                                  |

This certificate is being furnished solely for purposes of Section 906 and is not being filed as part of the PeriodicReport.
|  Date:  July 17,2003                 |                             | **/s/ Frederick S.Cromer                          ** |
|-------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                  | Frederick S. Cromer Vice President and Chief Financial Officer |

A signed original of this written statement required by Section 906 has been provided to ExpressJet Holdings, Inc. and will beretained by ExpressJet Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 00-1239

FRANCIS ZEKANIS,

Plaintiff - Appellant,

versus

UNITED STATES OF AMERICA,

Defendant - Appellee,

and

VA MEDICAL CENTER, MARTINSBURG, WEST VIRGINIA;

DONALD K. STEVENS, Recreation Specialist, VA

Medical Center, Martinsburg; PM&R RECREATION

ASSISTANT,

Defendants.

Appeal from the United States District Court for the Northern District of West Virginia, at Martinsburg. W. Craig Broadwater, District Judge. (CA-99-62, CA-99-63)

Submitted: June 30, 2000 Decided: October 6, 2000

Before LUTTIG and MICHAEL, Circuit Judges, and HAMILTON, Senior

Circuit Judge.

Affirmed by unpublished per curiam opinion.
2

Francis Zekanis, Appellant Pro Se. Patrick Michael Flatley, Assistant United States Attorney, Wheeling, West Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).

PER CURIAM:

Francis Zekanis appeals the district court’s order dismissing

this action for failure to exhaust his administrative remedies in

accordance with the provisions of the Federal Tort Claims Act. We

have reviewed the record and the district court’s opinion and find

no reversible error. Accordingly, we affirm on the reasoning of

the district court. See Zekanis v. United States, Nos. CA-99-62;

CA-99-63 (N.D.W. Va. Feb. 14, 2000). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid

the decisional process.

AFFIRMED
[Federal Register Volume 89, Number 25 (Tuesday, February 6, 2024)]
[Notices]
[Page 8222]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02345]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID SBIR Phase II Clinical Trial 
Implementation Cooperative Agreement (U44 Clinical Trial Required), 
Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed), 
Clinical Trial Implementation Cooperative Agreement (U01 Clinical 
Trial).
    Date: March 6, 2024.
    Time: 10:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Rockville, MD 
20892 (Virtual Meeting).
    Contact Person: Annie Walker-Abbey, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, MSC 9834, 
Rockville, MD 20852, 240-627-3390, <a href="/cdn-cgi/l/email-protection#2746464545425e67494e464e4309494e4f09404851"><span class="__cf_email__" data-cfemail="1372727171766a537d7a727a773d7d7a7b3d747c65">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: February 1, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-02345 Filed 2-5-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-2001
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               DEC-31-2000
<CASH>                                          67,414
<SECURITIES>                                         0
<RECEIVABLES>                                    4,297
<ALLOWANCES>                                       (98)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                72,916
<PP&E>                                           4,833
<DEPRECIATION>                                  (2,079)
<TOTAL-ASSETS>                                  78,453
<CURRENT-LIABILITIES>                           11,012
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            24
<OTHER-SE>                                      67,199
<TOTAL-LIABILITY-AND-EQUITY>                    78,453
<SALES>                                         22,939
<TOTAL-REVENUES>                                22,939
<CGS>                                            3,686
<TOTAL-COSTS>                                    3,686
<OTHER-EXPENSES>                                17,783
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              (1,877)
<INCOME-PRETAX>                                  3,347
<INCOME-TAX>                                     1,238
<INCOME-CONTINUING>                              2,109
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,109
<EPS-BASIC>                                        .14
<EPS-DILUTED>                                      .12


</TABLE>
II

104TH CONGRESS

1ST SESSION S. 61

To amend title XIX of the Social Security Act to provide for coverage

of services provided by nursing school clinics under State medicaid programs, and for other purposes.

IN THE SENATE OF THE UNITED STATES

JANUARY 4, 1995

Mr. INOUYE introduced the following bill; which was read twice and referred

to the Committee on Finance

A BILL

To amend title XIX of the Social Security Act to provide

for coverage of services provided by nursing school clinics

under State medicaid programs, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. MEDICAID COVERAGE OF SERVICES PROVIDED

4 BY NURSING SCHOOL CLINICS.

5 (a) IN GENERAL.—Section 1905(a) of the Social

6 Security Act (42 U.S.C. 1396d(a)) is amended—

7 (1) in paragraph (24), by striking ‘‘and’’ at the

8 end;
2

•S 61 IS

1 (2) by redesignating paragraph (25) as para2 graph (26); and

3 (3) by inserting after paragraph (24), the fol4 lowing new paragraph:

5 ‘‘(25) nursing school clinic services (as defined

6 in subsection (t)) furnished by or under the super7 vision of a nurse practitioner or a clinical nurse spe8 cialist (as defined in section 1861(aa)(5)), whether

9 or not the nurse practitioner or clinical nurse spe10 cialist is under the supervision of, or associated with,

11 a physician or other health care provider; and’’.

12 (b) NURSING SCHOOL CLINIC SERVICES DEFINED.—

13 Section 1905 of such Act (42 U.S.C. 1396d) is amended

14 by adding at the end the following new subsection:

15 ‘‘(t) The term ‘nursing school clinic services’ means

16 services provided by a health care facility operated by an

17 accredited school of nursing which provides primary care,

18 long-term care, mental health counseling, home health

19 counseling, home health care, or other health care services

20 which are within the scope of practice of a registered

21 nurse.’’.

22 (c) CONFORMING AMENDMENTS.—Section 1902 of

23 such Act (42 U.S.C. 1396a) is amended—

24 (1) in subsection (a)(10)(C)(iv), by striking

25 ‘‘through (24)’’ and inserting ‘‘through (25)’’; and
3

•S 61 IS

1 (2) in subsection (j), by striking ‘‘through (25)’’

2 and inserting ‘‘through (26)’’.

3 (d) EFFECTIVE DATE.—The amendments made by

4 this Act shall be effective with respect to payments under

5 title XIX of the Social Security Act for calendar quarters

6 commencing with the first calendar quarter beginning

7 after the date of the enactment of this Act.

Æ
**EXHIBIT      32**

**Certification      of CEO and CFO Pursuant to**

**18      U.S.C. Section 1350,**

**As      Adopted Pursuant to**

**Section      906 of the Sarbanes-Oxley Act of 2002**

|                                                                  |   |   |   |
|-----------------------------------------------------------------------|--------|--------|--------|
| /s/ Donald              R.              Uzzi                     |   |   |   |
| Donald R. Uzzi                                                        |   |   |        |
| Title:              Chairman              and Chief Executive Officer |   |   |   |
|                                                     |   |   |   |
|----------------------------------------------------------|--------|--------|--------|
| /s/ Allyson              Vanderford                 |   |   |   |
| Allyson Vanderford                                       |   |   |        |
| Title:              Chief              Financial Officer |   |   |   |
·              **EXHIBIT 32.1**

**CERTIFICATIONOF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THESARBANES-OXLEY ACT OF 2002**

In connection withthe Quarterly Report of iPCS, Inc. (the “Company”) on Form 10-Q forthe quarter ended June 30, 2007, as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), each of the undersigned certify,pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of theSarbanes-Oxley Act of 2002, that:

(1) The Report fullycomplies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

(2) Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.
| /s/   Timothy  M. Yager                                                    |   |
|--------------------------------------------------------------------------------------|--------|
| Timothy M. Yager, President and Chief Executive  Officer                             |
| August 6, 2007                                                                  |
|                                                                                 |
|                                                                                 |
| /s/   Stebbins  B. Chandor, Jr.                                       |   |
| Stebbins B. Chandor, Jr., Executive Vice  President and Chief Financial Officer |
| August 6, 2007                                                                  |

 

----
CERTIFICATION OF
                          CHIEF EXECUTIVE OFFICER AND
                            CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the accompanying amended Quarterly Report on Form 10-QSB of
Burnam Management, Inc.for the quarter ending August 31, 2002, I, Rick
Plotnikoff, Chief Executive Officer and Chief Financial Officer of Burnman
Management Inc. hereby certify pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to section 906 of the Sarbanes-Oxley Act of 2002, to the best of my
knowledge and belief, that:

     1.   Such amended Quarterly Report of Form 10-QSB for the period ending
          August 31, 2002, fully complies with the requirements of Section 13(a)
          or 15(d) of the Securities Exchange Act of 1934; and

     2.   The information contained in such amended Quarterly Report on Form
          10-QSB for the period ended August 31, 2002, fairly represents in all
          material respects, the financial condition and results of operations
          of Burnam Management, Inc.

Dated:    April 26, 2004

Burnman Management, Inc.

By:  /s/ Rick Plotnikoff
-----------------------------------------
Chief Executive Officer
Chief Financial Officer
UNITED STATES AIR FORCE

COURT OF CRIMINAL APPEALS

________________________

No. ACM S32287 (f rev)

________________________

UNITED STATES

Appellee

v.

Zavian M.T. ADDISON

Airman First Class, U.S. Air Force, Appellant

________________________

Appeal from the United States Air Force Trial Judiciary

Upon Further Review

Decided 9 January 2017

________________________

Military Judge: Gregory O. Friedland.

Approved sentence: Bad-conduct discharge, confinement for 30 days, and reduction to the grade of E-1. Sentence adjudged 3 December 2014 by SPCM 

convened at Joint Base Pearl Harbor-Hickam, Hawaii. 

For Appellant: Major Mark C. Bruegger.

For Appellee: Colonel Katherine E. Oler.

Before DUBRISKE, BENNETT, and C. BROWN, Appellate Military Judges

________________________

This is an unpublished opinion and, as such, does not serve as precedent under AFCCA Rule of Practice and Procedure 18.4.

________________________

PER CURIAM:

This case is before us for further review after our superior court set aside 

this court’s previous decision and the original convening authority’s action. 

United States v. Addison, 75 M.J. 405 (C.A.A.F. 2016). The record was returned 

to the Judge Advocate General of the Air Force for remand to an appropriate 

convening authority for a new staff judge advocate’s recommendation (SJAR)
United States v. Addison, No. ACM S32287 (rem)

2

and convening authority’s action. Id. The post-trial processing has been re-accomplished with the convening authority approving the same sentence as was 

originally approved. We now review the case on its merits.

We note the addendum to the SJAR did not specifically advise the convening authority of his mandatory requirement to consider the SJAR and the report of result of trial before taking action. See Rule for Courts-Martial 

1107(b)(3)(A); Air Force Instruction (AFI) 51-201, Administration of Military 

Justice, ¶ 9.20.1.2 (6 June 2013). Given the convening authority noted he reviewed all matters attached to the addendum, including the SJAR and report 

of result of trial, and ultimately approved a sentence in accordance with the 

pretrial agreement, we find no prejudice. The consistent use of post-trial processing templates found in AFI 51-201 will eliminate these unnecessary errors 

and better facilitate accurate post-trial processing.

The approved findings and sentence are correct in law and fact, and no error prejudicial to the substantial rights of Appellant occurred. Articles 59(a) 

and 66(c), UCMJ, 10 U.S.C. §§ 859(a), 866(c2). Accordingly, the findings and 

sentence are AFFIRMED.

FOR THE COURT

KURT J. BRUBAKER

Clerk of Court
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, William McGinty, President, Secretary and Treasurer of Global Innovative Systems, Inc., hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	the quarterly report on Form 10-QSB of Global Innovative Systems, Inc. for the period ended March 31, 2004 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Global Innovative Systems, Inc.

Dated: May 13, 2004

/s/ William McGintyWilliam McGinty
President, Secretary and Treasurer
(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Global Innovative Systems, Inc. and will be retained by Global Innovative Systems, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Orderentered February 8, 2013

In The 

# Qeourt of**~peal~** 

# jftftb**J}t~trttt** 

# of**tleexa~** 

# at**ilBalla~** No. 05-12-01630-CV CLIFTONALLEN, ET AL., Appellants 

# v. BANK OFAMERICA, N.A., Appellee On Appeal from the County Court at Law No. 2 Dallas County,Texas Trial Court Cause No. CC-12-04878-B 

### ORDER We GRANT the motion filed by Lanetta Williams, Official Court Reporter for County Court at Law No. 2 of Dallas County, Texas, for an extension of time to file the reporter's record. The reporter's record shall be filed on or before March 4, 2013. 

### Is/ CAROLYN WRIGHT CHIEF JUSTICE



## •
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

# AGENCY:

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

# ACTION:

Notice of charter renewal.

# SUMMARY:

This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the Lead Exposure and Prevention Advisory Committee (LEPAC), Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through January 17, 2026.

# FOR FURTHER INFORMATION CONTACT:

                        Paul Allwood, Ph.D., MPH, Designated Federal Officer, National Center for Environmental Health, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road NE, MS S106-5, Atlanta, Georgia 30329-4018. Telephone (770) 488-6774;                         *PAllwood@cdc.gov*.                    

# SUPPLEMENTARY INFORMATION:

CDC is providing notice under 5 U.S.C. 1001-1014 of the renewal of the charter of the Lead Exposure and Prevention Advisory Committee, Centers for Disease Control and Prevention, Department of Health and Human Services. This charter has been renewed for a two-year period through January 17, 2026.

                    The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign                     **Federal Register**                     notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.                

Kalwant Smagh,

Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.

[FR Doc. 2024-02179 Filed 2-2-24; 8:45 am]

BILLING CODE 4163-18-P